WestRock Company (NYSE:WRK) today announced that D. Michael Wilson will be the chief executive officer of the company’s specialty chemicals business that is expected to become a publicly traded company, Ingevity, early next year as a result of a spin-off from WestRock. He will join the company on September 1, 2015.
“Michael Wilson brings breadth and depth of specialty chemicals experience to Ingevity,” said Steve Voorhees, chief executive officer of WestRock. “His exceptional leadership skills and outstanding track record of delivering results will serve Ingevity and its stockholders well.”
Michael comes to Ingevity from Albemarle Corporation where he most recently served as executive vice president leading Albemarle’s Performance Chemicals business. Prior to that, Michael led Albemarle’s Catalyst Solutions business and held a variety of business unit leadership roles at FMC, Wausau Papers and Rexam. He holds a bachelor of science degree in chemistry from the University of North Carolina and a master of business administration from the Kenan-Flagler Business School at the University of North Carolina.
Director, Communications & Brand Management